A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Conditions: Recurrent Acute Leukemia of Ambiguous Lineage; Recurrent Acute Lymphoblastic Leukemia; Recurrent Mixed Phenotype Acute Leukemia; Refractory Acute Leukemia of Ambiguous Lineage; Refractory Acute Lymphoblastic Leukemia; Refractory Mixed Phenotype Acute Leukem ia Interventions: Procedure: Biospecimen Collection; Drug: Calaspargase Pegol-mknl; Drug: Cytarabine; Procedure: Echocardiography; Drug: Fludarabine Phosphate; Drug: Hydrocortisone Sodium Succinate; Drug: Methotrexate; Procedure: Multigated Acquisition Scan; Drug: Pegasparg ...
Source: ClinicalTrials.gov - March 9, 2023 Category: Research Source Type: clinical trials